(Q36952970)

17 August 2017

1 reference

title

Clinical considerations regarding treatment of hypercholesterolemia in the elderly (English)

1 reference

Cardiology and cardiovascular medicine

17 August 2017

0 references

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

26 November 2022

1

Bilheimer DW

1 reference

17 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1789816

26 November 2022

publication date

1 December 1991

1 reference

full work available at URL

17 August 2017

https://api.elsevier.com/content/article/PII:002191509190205H?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

https://api.elsevier.com/content/article/PII:002191509190205H?httpAccept=text/plain

26 November 2022

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

26 November 2022

1 reference

17 August 2017

91 Suppl

1 reference

17 August 2017

S35-57

1 reference

The care of elderly patients with cardiovascular disease

17 August 2017

2

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Cardiovascular risk factors in the elderly

26 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Hospital care for elderly patients with diseases of the circulatory system. A comparison of hospital use in the United States and Canada

26 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Health promotion and the compression of morbidity

26 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Treatment of hypercholesterolemia in the elderly

26 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Hypercholesterolemia in elderly persons: resolving the treatment dilemma

26 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Lipid levels and risk of atherosclerotic coronary heart disease in the older person.

26 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Ischemic heart disease, atherosclerosis, and longevity.

26 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Treating high blood cholesterol in the older patient

26 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Nutritional contributors to cardiovascular disease in the elderly

26 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Nutrition and the occurrence and prevention of cardiovascular disease in the elderly

26 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Prevention of cardiovascular disease among the elderly

26 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Determinants of cardiovascular diseases in the elderly

26 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Risk factor modification trials: implications for the elderly

26 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Evaluation of cardiovascular risk in the elderly: the Framingham study

26 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Predicting coronary heart disease in middle-aged and older persons. The Framington study

26 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men.

26 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Proportional hazards analysis of risk factors for coronary heart disease in individuals aged 65 or older. The Framingham Heart Study

26 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Cholesterol and coronary heart disease. The importance of patient-specific attributable risk

26 November 2022

27

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

The place of HDL in cholesterol management. A perspective from the National Cholesterol Educational Program

26 November 2022

28

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

High-density lipoprotein--the clinical implications of recent studies

26 November 2022

29

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Distribution of high density and other lipoproteins in selected LRC prevalence study populations: A brief survey

26 November 2022

30

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E.

26 November 2022

31

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Atherogenesis: a postprandial phenomenon

26 November 2022

32

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

A receptor-mediated pathway for cholesterol homeostasis

26 November 2022

33

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Two independent lipoprotein receptors on hepatic membranes of dog, swine, and man. Apo-B,E and apo-E receptors

26 November 2022

34

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Kinetic mechanisms determining variability in low density lipoprotein levels and rise with age.

26 November 2022

35

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Genetics of the low density lipoprotein receptor. Diminished receptor activity in lymphocytes from heterozygotes with familial hypercholesterolemia

26 November 2022

36

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

On the associations of body cholesterol pool size with age, HDL cholesterol and plasma total cholesterol concentration in humans

26 November 2022

38

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study

26 November 2022

39

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Cardiovascular effects of endogenous and exogenous sex hormones over a woman's lifetime

26 November 2022

40

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Menopause and risk factors for coronary heart disease

26 November 2022

41

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Lifetime risks of hip, Colles', or vertebral fracture and coronary heart disease among white postmenopausal women.

26 November 2022

42

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin

26 November 2022

47

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

26 November 2022

48

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Therapeutic control of hyperlipidemia in the prevention of coronary atherosclerosis: a review of results from recent clinical trials

26 November 2022

49

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid

26 November 2022

50

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts

26 November 2022

51

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

26 November 2022

53

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Cardiovascular disease in the very elderly. Analysis of 40 necropsy patients aged 90 years or over

26 November 2022

54

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

George Lyman Duff memorial lecture. Progression and regression of atherosclerotic lesions. Insights from lipid physical biochemistry.

26 November 2022

57

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Reversal of atherosis and sclerosis. The two components of atherosclerosis

26 November 2022

58

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

The decline in mortality from coronary heart disease, U.S.A., 1968--1975

26 November 2022

59

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

The decline in ischemic heart disease mortality rates. An analysis of the comparative effects of medical interventions and changes in lifestyle

26 November 2022

60

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel

26 November 2022

61

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery

26 November 2022

63

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Hypertension in elderly patients

26 November 2022

64

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Beneficial Six-Year Outcome of Smoking Cessation in Older Men and Women with Coronary Artery Disease

26 November 2022

65

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Effects of antihypertensives on plasma lipids and lipoprotein metabolism

26 November 2022

66

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Recommendations of the Adult Treatment Panel of the National Cholesterol Education Program. Implications for the management of hypertension

26 November 2022

67

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Treatment of hypertension in the elderly

26 November 2022

68

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

New insights and new approaches for the treatment of essential hypertension: selection of therapy based on coronary heart disease risk factor analysis, hemodynamic profiles, quality of life, and subsets of hypertension

26 November 2022

69

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Management of drug therapy in the elderly

26 November 2022

72

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Clinical pharmacokinetic considerations in the elderly. An update

26 November 2022

74

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Cholesterol-lowering effects of psyllium hydrophilic mucilloid for hypercholesterolemic men

26 November 2022

76

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Cholesterol-lowering effects of psyllium hydrophilic mucilloid. Adjunct therapy to a prudent diet for patients with mild to moderate hypercholesterolemia

26 November 2022

77

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

Some of the tough decisions required by a national health plan

26 November 2022

83

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90205-H

26 November 2022

Identifiers

1 reference

17 August 2017

1 reference